Form 4 for BSX Boston Scientific
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-11 · accession 0001225208-25-001685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | 2025-02-12 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $105.06 | -13.0K | 28.5K | -31% | -$1.37M | |
| 2025-02-13 | 2025-02-11 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $105.98 | -10.7K | 41.5K | -21% | -$1.14M | |
| 2025-02-13 | 2025-02-11 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | A - Grant | $0.00 | +23.8K | 52.2K | +84% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | S | D | 13,022 | $105.06 | 28,454 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.787 to $105.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-02-11 | F | D | 10,738 | $105.98 | 41,476 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-11 | A | A | 23,760 | $0.00 | 52,214 | D | — | — |